Changes in postmenopausal hormone replacement therapy use among women with high cardiovascular risk.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 19833984.
- Also identified by DOI 10.2105/AJPH.2009.159889 and PMC identifier 2775780.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
After randomized trials failed to support the use of hormone replacement therapy (HRT) for preventing cardiovascular disease (CVD), HRT use for postmenopausal women declined. Our analysis of 1999-2000 and 2003-2004 National Health and Nutrition Surveys (NHANES) shows that HRT use decreased 19% (from 27.6 to 8.4%; P<.001) among women with CVD versus 3% (from 19.8 to 16.8%; P=.68) among low-risk women, suggesting that most of the drop in HRT use may be among women prescribed HRT as an unproven treatment to prevent CVD.
Medical subject headings
- Cardiovascular Diseases
- Estrogen Replacement Therapy